Sarah Cannon Research Institute Sarah Cannon Research Inst (51 — Nashville, Tennessee

Sarah Cannon Research Institute Sarah Cannon Research Inst (51 is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute Sarah Cannon Research Inst (51 has participated in 1 clinical trials.

Therapeutic areas: Solid Tumor and Hematologic Malignancies.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute Sarah Cannon Research Inst (51?

Sarah Cannon Research Institute Sarah Cannon Research Inst (51 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute Sarah Cannon Research Inst (51 conducted?

Sarah Cannon Research Institute Sarah Cannon Research Inst (51 has 1 clinical trials on record. Their work covers Solid Tumor and Hematologic Malignancies.

Is Sarah Cannon Research Institute Sarah Cannon Research Inst (51 accredited by Crixeo Clinical Trials?

Sarah Cannon Research Institute Sarah Cannon Research Inst (51 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute Sarah Cannon Research Inst (51?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.